NCT07029776 2026-03-03MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple MyelomaUniversity of ArkansasPhase 2 Not yet recruiting50 enrolled
NCT06744894 2024-12-20SIL as Maintenance Therapy in Multiple MyelomaNavy General Hospital, BeijingPhase 2 Not yet recruiting50 enrolled